Molecular Classification
Enzyme, Serine protease, Peptidase S1 family, PA clan of proteases
Other Names
Chymotrypsin, Chymotrypsin A, Chymotrypsin B, Chymar, Alpha-chymar, Chymotest, Quimar, Quimotrase, Enzeon, Ophth, Avazyme, α-Chy
Disease Roles
Other (used as a therapeutic enzyme and in surgery)Inflammation (rarely, when used externally)Infection (adjunct use in ophthalmologic surgery)

Alpha-chymotrypsin Overview

Alpha-chymotrypsin is a serine protease enzyme produced in the pancreas as an inactive precursor (chymotrypsinogen) and activated in the duodenum by trypsin cleavage. It catalyzes the hydrolysis of peptide bonds on the carboxyl side of large hydrophobic amino acids such as phenylalanine, tryptophan, and tyrosine, playing a critical role in protein digestion. Structurally, it is characterized by three peptide chains held together by disulfide bonds and a catalytic triad (serine, histidine, aspartate) that orchestrates nucleophilic attack on peptide substrates. Besides its digestive role, alpha-chymotrypsin is used therapeutically as an anti-inflammatory and proteolytic agent in surgery, particularly ophthalmic procedures. Loss of enzyme activity can occur due to denaturation from heat or pH changes, and allergic or irritant reactions may rarely limit its clinical use[1][2][3][4][5][7].

Mechanism of Action

Proteolytic cleavage of peptide bonds C-terminal to aromatic amino acids (tyrosine, tryptophan, phenylalanine) in proteins and polypeptides, via a covalent hydrolysis (ping-pong) mechanism involving a catalytic triad (Ser195, His57, Asp102)[1][2][3][5]

Biological Functions

Proteolysis (breakdown of proteins and polypeptides)
Digestion in the small intestine
Activation of digestive enzyme cascades

Disease Associations

Other (used as a therapeutic enzyme and in surgery)
Inflammation (rarely, when used externally)
Infection (adjunct use in ophthalmologic surgery)

Safety Considerations

  • Allergic reactions (rare, in some patients upon administration)
  • Potential for local tissue irritation
  • instability at extremes of pH or temperature
  • loss of enzyme activity due to denaturation at high temperature or improper storage[4][6][7]

Interacting Drugs

None as direct inhibitors used therapeutically; chymotrypsin itself is used as a therapeutic enzyme[7]

Associated Biomarkers

Biomarker
None commonly used for patient selection or efficacy monitoring